Biotech News
TherapeuticsMD Announces Third Quarter 2024 Financial Results
ir.therapeuticsmd.com2026-05-06 15:14 EST
BOCA RATON, Fla. --(BUSINESS WIRE)--Nov. 12, 2024-- TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2024 .